Viral-induced neurodegenerative disease

Current Opinion in Microbiology

Volumn 2, Issue 4, 1999, Pages 398-402

  Buchmeier, Michael J ^a   Lane, Thomas E ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEGENERATIVE DISEASE; IMMUNE RESPONSE; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; REVIEW; VIRUS INFECTION;

EID: 0033179295     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(99)80070-8     Document Type: Review

References (38)

1. Kennedy PGE, Steiner I: On the possible viral etiology of multiple sclerosis. Q J Med 1994, 87:523-528.
2. Nathan C, Xie QW: Nitric oxide syntheses: Roles, tolls, and controls. Cell 1994, 78:915-918.
3. Bo L, Wesselingh DT, Mork S, Choi S, Kong PA, Hanley D, Trapp BD: Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994, 36:778-786.
4. McCann S: The nitric oxide hypothesis of brain aging. Exp Gerontol 1997, 32:431-440.
5. Reiss C, Komatsu TK: Does nitric oxide play a critical role in viral infections? J Virol 1998, 72:4547-4551.
6. Sun N, Grzybicki DM, Castro F, Murphy S, Perlman S: Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 1995, 213:482-493.
7. Grzybicki DM, Perlman S, Murphy SP: Nitric oxide synthase type II expression by different cell types in MHV-JHM encephalitis suggests distinct roles for nitric oxide in acute versus persistent virus infection. J Neuroimmunol 1997, 73:15-27.
8. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE: Microglial cell cytotoxicity of olugodendrocytes is mediated through nitric oxide. J Immunol 1993, 151:2132-2141.
9. Dawson VTD: Nitric oxide in neurodegeneration. Prog Brain Res 1998, 118:215-229. Provides an excellent overview of the pathophysiology effects of nitric oxide (NO) production within the central nervous system (CNS) and how it may contribute to various neurological disorders as well as microbial-induced injury.
10. Estevez A, Spear N, Manuel SM, Barbeito L, Radi R, Beckman JS: Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture. Prog Brain Res 1998, 118:269-280.
11. Oleszak EL, Katsetos CD, Kuzmak J, Varadhachary A: Inducible nitric oxide synthase in Theiler's murine encephalomyelitis virus infection. J Virol 1997, 71:3228-3235.
12. Rose JW, Hill KE, Wada Y, Jurtz CI, Tsunoda I, Fujinami RS, Cross AH: Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection. J Neuroimmunol 1998, 81:82-89. To our knowledge, the first such paper which examined how aminoguanidine (AG) administration modulates the severity of virus-induced central nervous system (CNS) disease. A well done study that demonstrates that NOS2-derived nitric oxide (NO) is important in contributing to CNS inflammation and demyelination following CNS infection with Theiler's virus.
13. Lane TE, Puoletti AD, Buchmeier MJ: Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J Virol 1997, 71:2202-2210.
14. Lane T, Fox HS, Buchmeier MJ: Inhibition of nitric oxide synthase-2 reduces the severity of mouse hepatitis virus-induced demyelination: Implications for NOS2/NO regulation of chemokine expression and inflammation. J Neurovirol 1999, 5:48-54.
15. Weiss JM, Downie SA, Lyman WD, Berman JW: Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J Immunol 1998, 161:6896-6903. A well-conceived study that carefully examines how chemokine expression may contribute to leukocyte migration across the blood-brain barrier and thus contribute to central nervous system (CNS) inflammation.
16. Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A: Chemokines and chemotaxis of leukocytes in infectious meningitis. J Neuroimmunol 1998, 85:33-43.
17. Benveniste EN: Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action. The American Physiological Society 1992, C1-C16.
18. Merrill J, Benveniste EN: Cytokines in inflammatory brain lesions: Helpful and harmful. Trends Neurosci 1996, 19:331-338.
19. Lane TE, Perlman S, Buchmeier MJ: Coronaviruses: Hepatitis and central nervous system disease. In Effects of Microbes on the Immune System. Edited by Cunningham M, Fujinami R. Philadelphia: Lippincott-Raven; 1999:in press.
20. Parra B, Hinton DR, Lin MT, Cua DJ, Stohlman SA: Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology 1997, 233:260-270.
21. Sato S, Reiner SL, Jensen MA, Roos RP: Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection. J Neuroimmunol 1997, 76:213-223.
22. Ransohoff R, Glabinski A, Tani M: Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev 1996, 7:35-46.
23. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ: Dynamic regulation of alpha and beta chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 1998, 160:970-978. Provides evidence of differential expression of chemokine genes following viral infection of the central nervous system (CNS), which first suggested a role for these molecules in contributing to the pathogenesis of virus-induced inflammation and demyelination.
24. Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA: IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol 1999, 162:1641-1647. Interesting and important contribution to our understanding of the selectivity of cytokine-mediated control of viral growth with the central nervous system (CNS).
25. Lin M, Hinton DR, Parra B, Stohlman SA, van der Veen RC: The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology 1998, 245:270-280.
26. Stohlman SA, Yao Q, Bergmann CC, Tahara SM, Kyuwa S, Hinton DR: Transcription and translation of proinflammatory cytokines following JHMV infection. Adv Exp Med Biol 1995, 380:173-178.
27. Joseph J, Grun JL, Lublin FD, Knobler RL: Interleukin-6 induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (MHV-4, JHM). J Neuroimmunol 1993, 42:47-52.
28. Hvas J, Bernard CC: Molecular detection and quantitation of the chemokine RANTES mRNA in neurological brain. APMIS 1998, 106:598-604. Excellent study that reports the presence of the chemokine RANTES within plaque lesions of patients with multiple sclerosis (MS) thus indicating a role for this chemokine in the pathogenesis of MS.
29. Miller SD, Karpus WJ: The immunopathogenesis and regulation of T-cell mediated demyelinating diseases. Immunol Today 1994, 15:356-361.
30. Pettinelli CB, McFarlin DE: Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: Requirement for Lyt 1+2- T lymphocytes. J Immunol 1981, 127:1420-1423.
31. + T cells to inflammation and demyelination following infection with Theiler's virus. The data suggest distinct roles for each T cell subset in contributing to disease pathology.
32. Fleming JO, Wang FI, Trousdale MD, Hinton DR, Stohlman SA: Interaction of immune and central nervous systems: Contribution of anti-viral Thy-1-f- cells to demyelination induced by coronavirus JHM. Regional Immunology 1993, 5:37-43.
33. Houtman JJ, Fleming J: Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J Neurovirol 1996, 2:101-110.
34. + T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. J Neurovirol 1997, 3:225-228.
35. Wang F, Stohlman S, Fleming J: Demyelination induced by murine hepatitis virus JHM (MHV-4) is immunologically mediated. J Neuroimmunol 1990, 30:31-41.
36. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS: Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997, 3:1133-1136.
37. Haspel MV, Lampert PW, Oldstone MB: Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc Natl Acad Sci USA 1977, 75:4033-4036.
38. Barnett LA, Fujinami RS: Molecular mimicry: A mechanism for autoimmune injury. FASEB J 1992, 6:840-844.